Patient Recruitment and Enrollment in Clinical Trials

Recruiting participants for clinical trials can be tougher than conducting the trials themselves. A delay in recruitment extends the study's timeline, pushing back the treatment's market availability. Take a look at the infographic below to understand how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.

Patient Recruitment and Enrollment Infographic

Discovering Clinical Trials

72% of participants are existing patients, while twenty-eight percent are new.
Top sources of clinical trial information:
58% from primary care physicians
40% from online registries
30% from search engines
19% from primary care nurses
19% from pharmaceutical companies
Motivations for Participation

Top perceived benefits:
26% to advance medicine
36% to improve others' lives
15% to improve their condition
8% as the best treatment option
5% for monetary compensation
Factors influencing participation:
Sixty percent physical location
Sixty-three percent confidentiality
73% types of procedures
75% study purpose
Eighty-three percent potential risks and benefits
Enrollment Challenges

Thirty-seven percent of sites under-enroll, with eleven percent failing to enroll any patients.
Doubling original timelines helps ninety percent of trials meet enrollment goals.
70% of the public haven't considered clinical trials, with 19% unwilling to participate and 7% unsure.
Top perceived risks:
Forty percent side effects
Thirty-three percent overall health risks
Seven percent receiving placebo
7% stopping beneficial treatments
40% lack confidence in finding a suitable study, and seventy percent seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: Seventy-four percent are open to discussing trial participation in online peer communities, and click here 94% of volunteers would participate again.

To learn more visit our website at https://recruitqualified.com

Patient Recruitment and Enrollment in Clinical Trials

Leave a Reply

Your email address will not be published. Required fields are marked *